Gamal A Shazly

7PUBLICATIONS
14CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsMedical biotechnology not elsewhere classifiedPredictive and prognostic markersSurface properties of condensed matter
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 20, 2026
Delving Into the Depths of AGTR2: In Silico Identification of Deleterious Nonsynonymous SNPs Associated With Cardiovascular Diseases.

|Apr 13, 2026
Engineering of the Melanoma Inhibitor of Apoptosis (ML-IAP) Anticancer Peptide Through Comprehensive In Silico Approaches.

Haitham Ahmed Al-Madhagi, Muhammad Shahab, Zheng Guojun

|Nov 08, 2024
RETRACTED: Al-Wahaibi et al. Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells. Int. J. Mol. Sci. 2020, 21, 4138.

Lamya H Al-Wahaibi, Muneera S M Al-Saleem, Osama A A Ahmed

|Jun 14, 2020
RETRACTED: Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells.

Lamya H Al-Wahaibi, Muneera S M Al-Saleem, Osama A A Ahmed

|Sep 09, 2017
Corrigendum to "Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment".

Gamal A Shazly

|Feb 15, 2017
Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment.

Gamal A Shazly

Pageof 2

Frequent Collaborators

2 joint publications

Osama A A Ahmed

2 joint publications

Usama A Fahmy

2 joint publications

Nabil A Alhakamy

2 joint publications

Ashraf B Abdel-Naim